COVID-19 Infection in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor in Makassar, Indonesia: A Six-Case Report and Literature Review by Tutik Harjianti, Fachruddin Benyamin, Rahmawati Minhajat, Sahyuddin Saleh, Dimas Bayu, Wahyudi Pababbari

Subjects: Get full text

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy by Xu Zhang, Zhiguo Ai

Subjects: Get full text

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients by Anastasia Putri, Ikhwan Rinaldi, Melva Louisa, Soekamto Koesnoe

Subjects: Get full text

Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial by Liu Y, Li X, Zhang M, Men Y, Wang Y, Zhu X, Zheng L

Subjects: Get full text

The Prospective role of lapatinib as an adjuvant therapy in prevalent cancers: Insights from in silico analysis targeting EGFR and HER2 by Behnaz Dolatabadi, Maryam Peymani, Leila Rouhi, Ali Salehzadeh, Kiavash Hushmandi, Mehrdad Hashemi

Subjects: Get full text

Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance by Xian-Hao Xiao, Qian-Shi Zhang, Ji-Yuan Hu, Yin-Xu Zhang, He Song

Subjects: Get full text

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma by Dan Liu, Xia Yin, Hui Wang, Lijie Xing, Ping Li, Haichen Wei, Ji Ma, Qiang He, Linna Xie, Ke Lu, Zengjun Li

Subjects: Get full text

Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung by Vishwanath Sathyanarayanan, Kadabur Nagendrappa Lokesh, Lakshmaiah Kuntejowdahalli Channaviriappa, Linu Abraham Jacob

Subjects: Get full text

Key principles of drug therapy in patients with chronic myeloid leukemia by A. V. Zhuravlev, O. I. Knysh

Subjects: Get full text

COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE... by R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov

Subjects: Get full text

HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities by Ahmed Ismail, Aakash Desai, Yanis Boumber

Subjects: Get full text

Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET‐Guided Verification by Suzanne van derGaag, Tamara Jordens, Maqsood Yaqub, Robbin Grijseels, Daan W. vanValkengoed, Evelien N. deLangen, Ruben van denBroek, Victor L. J. L. Thijssen, Adrianus J. deLangen, Mathilde C. M. Kouwenhoven, Idris Bahce, Bart A. Westerman, N. Harry Hendrikse, Imke H. Bartelink

Subjects: Get full text

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies by Tomasz Sacha, Katarzyna Krawczyk

Subjects: Get full text

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension by Wenze Wu, Fanhao Kong, Zhen Chen, Lixin Huang, Xiaowei Nie, Jin‐Song Bian

Subjects: Get full text

Neddylation status determines the therapeutic sensitivity of tyrosine kinase inhibitors in chronic myeloid leukemia by Congyi Zhang, Yikai Yao, Qiuting Qian, Xiongyu Han, Yunkun Lu, Xinyi Jiang, Hongqiang Cheng, Xue Zhang, Ying Chi, Yuehai Ke, Peng Xiao

Subjects: Get full text

Positive results of treatment of adenocystic carcinoma of the parotid salivary gland with lenvatinib by I. A. Filippov, M. S. Shvedsky, E. A. Gaisina, L. A. Bakhova

Subjects: Get full text

Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: case report and literature review by Toshifumi Takahashi

Subjects: “…assisted reproductive technology, chronic myeloid leukemia, infertility, pregnancy, tyrosine kinase inhibitor…”
Get full text

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia by Chen J, Zhu Y, Zhao Y, Guo N, Yao Y, Luo X, Huang L

Subjects: “…tyrosine kinase inhibitor…”
Get full text

Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases by Nozomi Sasaki, Yukiko Enomoto, Takamitsu Hori, Hirofumi Matsubara, Yusuke Egashira, Tsuyoshi Izumo

Subjects: Get full text

Safety of Lorlatinib in Patients with Unresectable Advanced <i>ALK</i>-Positive Non-Small-Cell Lung Cancer Previously Treated with ALK Inhibitors: A Single-Arm, Open-Label, Phase I... by Ullas Batra, Vineet G. Gupta, Nirmal Raut, Tushar Patil, Harsha Panchal, Nikhil Ghadyalpatil, Anand Pathak, Chirag Desai, Shailesh Bondarde, Minish Jain, Christian Russel Reyes, Shyam Parvatini, Seema Pai, Francesca Toffalorio, Holger Thurm, Bivas Biswas

Subjects: “…ALK tyrosine kinase inhibitor…”
Get full text